Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 2Completed 2Unknown 1Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Classical hematology 1

Conditions

Pain, Intractable 1Neoplasms 1Mucositis 1Leukemia 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

Paclitaxel 3Surgical Procedures, Operative 2Radiotherapy 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Fluorouracil 2Doxorubicin 2Cyclophosphamide 2titanium silicide 1sargramostim 1exemestane 1eribulin 1cemiplimab 1Vincristine 1Taxes 1Tamoxifen 1Surveys and Questionnaires 1Specimen Handling 1S 1 (combination) 1Rituximab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Prednisone 1Prednisolone 1Passive Cutaneous Anaphylaxis 1Neoadjuvant Therapy 1Morphine 1Methylprednisolone 1Methotrexate 1Methods 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Suspended × Methadone × Clear all
NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡